Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
Risk of Cancer-Associated Thrombosis and Bleeding in Veterans With Malignancy Who Are Receiving Direct Oral
Matthew Stankowicz1, Megan Banaszynski1, Russell Crawford1
1is a PGY2 Oncology Pharmacy Resident, is a Clinical Pharmacist, and is a Clinical Pharmacist, all at Southern Arizona VA Health Care System in Tucson. Mr. Crawford is President of the Association of VA Hematology/Oncology (AVAHO).
Abstract:
The low incidence of venous thromboembolism formation in this study and similar rates of bleeding in other clinical trials indicate that direct oral anticoagulant agents are safe alternatives in patients with cancer.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Bleeding in Fresh Concrete
Bleeding can cause several issues in the concrete structure. Sometimes, the rising water gets trapped beneath large aggregate...
Venous Thrombosis I: Introduction
Receiver Operating Characteristic Plot
Relative Risk
Anticoagulant Drugs: Low-Molecular-Weight Heparins

